Biden’s Pandemic Preparedness Plan Targets Vaccine Design, FDA Regulatory Approaches
Executive Summary
Administration proposal is long on ambition, short on details; goals are to confront future pandemics, including improving vaccines and therapeutics, manufacturing capacity and supply chains.
You may also be interested in...
Biden’s ‘Test To Treat’ Plan Will Include Merck And Pfizer COVID Pills, But Only One Gets Public Thanks
Hundreds of pharmacy-based clinics and community health centers will offer free COVID testing and treatment. Government has secured 20 million doses of Pfizer’s Paxlovid, deemed to be a ‘game changer,’ though Merck’s molnupiravir is expected to be important in long-term care facilities.
Biden vs. Pharma: ‘You Come For The King…’
The president’s state of the union address comes after a year of mostly disappointing efforts for the administration on COVID and drug pricing.
ARPA-H: New Health Research Agency Faces Old Concerns About Disrupting Private Investment
Proposed Advanced Research Project Agency for Health also needs to distinguish itself from NCATS, which faced many of the same questions when it was created a decade ago. Disagreements also persist about whether ARPA-H should be housed in NIH or HHS.